VR Adviser, LLC Diversified Active

CIK: 0001615982 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 14, 2025

Total Value ($000): $1,457,403 (100.0% shares, 0.0% debt)

Holdings (37)

APGE APOGEE THERAPEUTICS INC 26.4%
Value ($000) $384,747 Shares 8,493,321 Est. Cost $22.03 Unrealized +131.5%
OCUL OCULAR THERAPEUTIX INC 7.5%
Value ($000) $108,991 Shares 12,762,462 Est. Cost $4.57 Unrealized +113.3%
ELVN ENLIVEN THERAPEUTICS INC 6.2%
Value ($000) $90,592 Shares 4,026,331 Est. Cost $18.38 Unrealized +41.0%
PRAX PRAXIS PRECISION MEDICINES I 5.2%
Value ($000) $76,189 Shares 989,985 Est. Cost $43.15 Unrealized +67.7%
VRDN VIRIDIAN THERAPEUTICS INC 5.1%
Value ($000) $74,432 Shares 3,882,709 Est. Cost $19.32 Unrealized +12.6%
ORKA ORUKA THERAPEUTICS INC 4.4%
Value ($000) $63,708 Shares 3,285,620 Est. Cost $34.16 Unrealized -28.6%
SYRE SPYRE THERAPEUTICS INC 4.3%
Value ($000) $62,517 Shares 2,685,448 Est. Cost $17.59 Unrealized +66.7%
PHVS PHARVARIS N V 4.2%
Value ($000) $61,730 Shares 3,220,130 Est. Cost $15.96 Unrealized +29.0%
KALV KALVISTA PHARMACEUTICALS INC 3.6%
Value ($000) $52,935 Shares 6,249,731 Est. Cost $8.81 Unrealized +17.5%
DYN DYNE THERAPEUTICS INC 3.5%
Value ($000) $51,217 Shares 2,173,913 Est. Cost $11.80 Unrealized +150.7%
COGT COGENT BIOSCIENCES INC 3.0%
Value ($000) $44,338 Shares 5,684,411 Est. Cost $8.47 Unrealized +17.7%
ERAS ERASCA INC 2.8%
Value ($000) $40,703 Shares 16,216,216 Est. Cost $2.16 Unrealized +27.1%
DNTH DIANTHUS THERAPEUTICS INC 2.6%
Value ($000) $38,027 Shares 1,744,373 Est. Cost $17.70 Unrealized +45.3%
UPB UPSTREAM BIO INC 2.6%
Value ($000) $37,735 Shares 2,295,319 Est. Cost $22.33 Unrealized 0.0%
ORIC ORIC PHARMACEUTICALS INC 2.4%
Value ($000) $35,464 Shares 4,394,527 Est. Cost $8.55 Unrealized +7.3%
ENGN ENGENE HOLDINGS INC 2.3%
Value ($000) $33,559 Shares 5,046,414 Est. Cost $10.25 Unrealized -24.2%
MERUS N V 1.7%
Value ($000) $24,911 Shares 592,411 Est. Cost $20.36 Unrealized
ASTRIA THERAPEUTICS INC 1.5%
Value ($000) $21,969 Shares 2,457,348 Est. Cost $8.36 Unrealized
CIDARA THERAPEUTICS INC 1.4%
Value ($000) $20,583 Shares 765,723 Est. Cost $26.88 Unrealized
CGEM CULLINAN THERAPEUTICS INC 1.2%
Value ($000) $16,808 Shares 1,379,965 Est. Cost $21.29 Unrealized -32.5%
FDMT 4D MOLECULAR THERAPEUTICS IN 1.1%
Value ($000) $16,445 Shares 2,952,371 Est. Cost $19.48 Unrealized -59.7%
ARTV ARTIVA BIOTHERAPEUTICS INC 1.1%
Value ($000) $16,224 Shares 1,609,569 Est. Cost $11.59 Unrealized +3.6%
MERSANA THERAPEUTICS INC 1.0%
Value ($000) $14,669 Shares 10,257,790 Est. Cost $1.27 Unrealized
ABVX ABIVAX SA 0.7%
Value ($000) $9,851 Shares 1,345,780 Est. Cost $11.63 Unrealized
AQST AQUESTIVE THERAPEUTICS INC 0.6%
Value ($000) $9,362 Shares 2,629,786 Est. Cost $3.33 Unrealized +38.5%
APPLIED THERAPEUTICS INC 0.6%
Value ($000) $8,554 Shares 9,990,591 Est. Cost $3.32 Unrealized
PCSC PERCEPTIVE CAP SOLUTIONS COR 0.5%
Value ($000) $7,635 Shares 750,000 Est. Cost $10.07 Unrealized +0.3%
TERN TERNS PHARMACEUTICALS INC 0.4%
Value ($000) $5,967 Shares 1,077,090 Est. Cost $4.28 Unrealized +58.3%
TSHA TAYSHA GENE THERAPIES INC 0.4%
Value ($000) $5,580 Shares 3,225,180 Est. Cost $1.87 Unrealized +11.1%
TRVI TREVI THERAPEUTICS INC 0.4%
Value ($000) $5,218 Shares 1,266,457 Est. Cost $2.46 Unrealized +29.9%
ZURA ZURA BIO LTD 0.3%
Value ($000) $5,058 Shares 2,023,166 Est. Cost $4.08 Unrealized -12.6%
IPSC CENTURY THERAPEUTICS INC 0.3%
Value ($000) $3,997 Shares 3,957,186 Est. Cost $3.84 Unrealized -64.5%
CASIF CASI PHARMACEUTICALS INC 0.2%
Value ($000) $2,794 Shares 987,259 Est. Cost $6.09 Unrealized -22.1%
TNYA TENAYA THERAPEUTICS INC 0.2%
Value ($000) $2,224 Shares 1,555,556 Est. Cost $4.78 Unrealized -53.1%
TENX TENAX THERAPEUTICS INC 0.1%
Value ($000) $1,290 Shares 208,333 Est. Cost $3.62 Unrealized +34.0%
GLYCOMIMETICS INC 0.1%
Value ($000) $747 Shares 3,000,000 Est. Cost $0.25 Unrealized
TIL INSTIL BIO INC 0.0%
Value ($000) $633 Shares 33,177 Est. Cost $23.54 Unrealized +29.5%